No Detail Found!

Comparison of the Effciency of Induction and Adjuvant Chemotherapy in Patients with Locally Advanced Nasopharyngeal Cancer

Author(s)
Mustafa Buyukkor Department of Medical Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital,Ankara,Turkey
Fatih Tay Department of Medical Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital,Ankara,Turkey
Aziz Kurtulus Department of Medical Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital,Ankara,Turkey
Ozturk Ates Department of Medical Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital,Ankara,Turkey
Abstract
Objective: To make a comparative evaluation of induction chemotherapy (ICT) or adjuvant chemotherapy (ACT) added to standard concurrent chemoradiotherapy in patients diagnosed with locally advanced nasopharyngeal cancer (LANPC) (Stage 3-4a patients, except T3N0). Study Design: Observational study. Place and Duration of the Study: Department of Medical Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey, from April 2009 to June 2021. Methodology: Clinicopathological features of adult patients diagnosed with LANPC were recorded from the hospital s patient registry database. Patients without the medical records were excluded. An assessment of the e ectiveness of induction or ACT added to standard de nitive chemoradiotherapy (CRT) was performed, and the application cycles were evaluated. Results: Seventy-four patients (71.6% male, mean age 50.8±11.7) with LANPC were included in the study. There is no statistical di erence in progression-free survival (PFS) between patients who applied ICT (before CRT) and ACT (after CRT) (p = 0.61). Female patients and patients aged d50 years had better PFS as independent factors (HR=3.82, 95% CI 1.14-12.74, p = 0.029; HR: 1.06 95% CI 1.02-1.10, p = 0.002, respectively). Also, patients aged 50 years and younger and female patients had a statistically longer overall survival (OS) (p = 0.045, and p = 0.012, respectively). While there was statistically no signi cant di erence in PFS according to the number of cycles for EBER-positive patients received adjuvant Cisplatin-5FU (CF); 3 cycles compared to 2 showed a statistically higher OS (p = 0.06, and p = 0.022, respectively). Conclusion: LANPC patients were found to have a positive survival if they were young and females. There was a positive impact on survival of intensi ed adjuvant CF in EBER-positive nonkeratinising, undi erentiated LANPC patients.
Publication Details
Page(s) 1141-1147
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 33, Issue: 10, Year: 2023

Request the full text from PASTIC

Keywords
Induction chemotherapy, EBER, Adjuvant chemotherapy, Locally advanced nasopharyngeal cancer
0

Citations

0

Downloads

76

Views